Gamma knife radiosurgery in the management of patients with acromegaly: A review

Pituitary

Volumn 4, Issue 4, 2001, Pages 223-230

  Mahmoud Ahmed, Ashraf S ^a   Suh, John H ^a   Mayberg, Marc R ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Acromegaly; Gamma knife radiosurgery; Review

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; BLEEDING; BRAIN EDEMA; BRAIN NECROSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; GROWTH HORMONE RELEASE; HEADACHE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; HYPOPHYSIS TUMOR; HYPOPITUITARISM; LATENT PERIOD; MORBIDITY; MORTALITY; OPTIC NERVE DISEASE; PATIENT SELECTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; STEREOTAXIC SURGERY; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT INDICATION; TUMOR RECURRENCE;

ACROMEGALY; HUMANS; RADIOSURGERY; STEREOTAXIC TECHNIQUES;

EID: 0035470181     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020794329975     Document Type: Review

References (63)

1. Swearingen B, Barker FG II, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419-3426.
2. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results. J Clin Endocrinol Metab 1998;83:3411-3418.
3. Bates AS, Van't Hoff W, Jones JM, Clayton RN. Does treatment of acromegaly affect life expectancy? Metabolism 1995;44:1-5.
4. Bengtsson BA, Eden S, Ernest I, Oden A, Sjogren B. Epidemiology and long-term-survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988;223:327-335.
5. Rajasoorya C, Holdaway IM, Wrightson P, et al. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 1994;41:95-102.
6. Giustina A, Barkan A, Casanueva FF, cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S. Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 2000;85:526-529.
7. First Scandinavian workshop on treatment of acromegaly: Treatment guidelines for acromegaly. Report from a Scandinavian workshop. GH & IGF Research 2001;11:72-74.
8. Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin J, Jenkins JP, Chew SL, Monson JP, Besser GM, Grossman AB. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 2001;86(4):1645-1652.
9. Weil MD. Stereotactic radiosurgery for brain tumors. Hematol Oncol Clin North Am 2001; 15(6):1017-1026.
10. Markes LB. Conventional fractionated radiation therapy vs. radiosurgery. J Neurooncol 1993;17:223-230.
11. Friedman WA, Foote KD. Linear accelerator radiosurgery in the management of brain tumors. Ann Med 2000;32:64-80.
12. Levy RP, Schulte RW, Slater JD, Miller DW, Slater JM. Stereotactic radiosurgery-the role of charged particles. Acta Oncol 1999;38:165-169.
13. Sims E, Doughty D, Macaulay E, Royle N, Wraith C, Darlison R, Plowman PN. Stereotactically delivered cranial radiation therapy: A ten-year experience of linac-based radiosurgery in the UK. Clin Oncol (R Coll Radiol) 1999; 11(5): 303-320.
14. Kondziolka D, Lunsford LD, Flickinger JC, Kestle JR. Reduction of hemorrhage risk after stereotactic radiosurgery for cavernous malformations. J Neurosurg 1995;83(5):825-831.
15. Link MJ, Coffey RJ, Nichols DA, Goman DA. The role of radiosurgery and particulate embolization in the treatment of dural arteriovenous fistulas. J Neurosurg 1996;84(5):804-809.
16. Pollock BE, Flickinger JC, Lunsford LD, Maitz A, Kondziolka D. Factors associated with successful arteriovenous malformation radiosurgery. Neurosurgery 1998;42(6):1239-1244.
17. Yamamoto Y, Coffey RJ, Nichols DA, Shaw EG. Interim report on the radiosurgical treatment of cerebral arteriovenous malformations: The influence of size, dose, time, and technical factors on obliteration rate. J Neurosurg 1995;83:832-837.
18. Foote RL, Coffey RJ, Swanson JW, Harner SG, Beatty CW, Kline RW, Stevens LN, Hu TC. Stereotactic radiosurgery using the gamma knife for acoustic neuromas. Int J Radiat Oncol Biol Phys 1995;15;32(4):1153-1160.
19. Kondziolka D, Lunsford LD, Coffey RJ, Flickinger JC. Stereotactic radiosurgery of meningiomas. J Neurosurg 1991;74:552-559.
20. Pollock BE, Kondziolka D, Lunsford LD, et al. Stereotactic radiosurgery for pituitary adenomas: Imaging, visual and endocrine results. Acta Neurochir Suppl (Wien) 1994; 62:33-38.
21. Pollock BE, Lunsford LD, Kondziolka D, Flickinger JC, Bissonette DJ, Kelsey SF, Jannetta PJ. Outcome analysis of acoustic neuroma management: A comparison of microsurgery and stereotactic radiosurgery. Neurosurgery 1995;36:215-224.
22. Kondziolka D, Lunsford LD, Flickinger JC, Young RF, Vermeulen S, Duma CM, Jacques DB, Rand RW, Regis J, Peragut JC, Manera L, Epstein MH, Lindquist C. Stereotactic radiosurgery for trigeminal neuralgia: A multi-institutional study using the gamma unit. J Neurosurg 1996;84(6):940-945.
23. Leksell L. The stereotactic method and radiosurgery of the brain. Acta Chir Scand 1951/1952;102:316-319.
24. Phillips MH, Stelzer KJ, Griffin TW, Mayberg MR, Winn HR. Stereotactic radiosurgery: A review and comparison of methods. J Clin Oncol 1994; 12(5):1085-1099.
25. Marcou Y, Plowman PN. Stereotactic radiosurgery for pituitary adenomas. Trends Endocrin Metab 2000; 11(4):132-137.
26. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G. Stereotactic radiosurgery for recurrent surgically treated acromegaly: Comparison with fractionated radiotherapy. J Neurosurg 1998;88(6):1002-1008.
27. Ikeda H, Jokura H, Yoshimoto T. Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma. J Neurosurg 2001;95(2):285-291.
28. Pollock BE, Gorman DA, Schomberg PJ, Kline RW. The Mayo Clinic gamma knife experience: Indications and initial results. Mayo Clinic Proceedings 1999;74(1):5-13.
29. Thoren M, Rahn T, Guo WY, Werner S. Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumors. Neurosurgery 1991;29(5):663-668.
30. Hayashi M, Izawa M, Hiyama H, Nakamura S, Atsuchi S, Sato H, Nakaya K, Sasaki K, Ochiai T, Kubo O, Hori T, Takakura K. Gamma Knife radiosurgery for pituitary adenomas. Stereotact Funct Neurosurg 1999;72(Suppl 1):111-118.
31. Witt TC, Kondziolka D, Flickinger JC, Lunsford LD. Gamma Knife radiosurgery for pituitary tumors. In Lunsford LD, Kondziolka D, Flickinger JC, eds. Gamma Knife Brain Surgery. Prog Neurol Surg. Basal: Krager 14. 1998:114-127.
32. Zierhut D, Flentje M, Adolph J, Erdmann J, aue F, Wannenmacher M. External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 1995;33:307-314.
33. Mokry M, Ramschak-Schwarzer S, Simbrunner J, Ganz JC, Pendi G. A six year experience with the postoperative radiosurgery management of pituitary adenomas. Stereotact Funct Neurosurg 1999;72(Suppl 1):88-100.
34. Al-Mefty O, Kersh JK, Routh A, Smith RR. The long term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 1990;73:502-512.
35. Jackson IM, Noren G. Role of gamma knife radiosurgery in acromegaly. Pituitary 1999;2(1):71-77.
36. Laws ER, Vance ML. Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin North Am 1999;2:157-166.
37. McCord MW, Buatti JM, Fennell EM, Mendenhall WM, Marcus RB Jr, Rhoton AL, Grant MB, Friedman WA. Radiotherapy for pituitary adenoma: Long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997;39:437-444.
38. Biermasz NR, Dulken HV, Roelfsema F. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels. Clin Endocrinol (Oxf) 2000;53(3):321-327.
39. Zhang N, Pan L, Wang EM, Dai JZ, Wang BJ, Cai PW. Radiosurgery for growth hormone-producing pituitary adenomas. J Neurosurg 2000;93(Suppl 3):6-9.
40. Fowler JF. Radiation-induced lung damage: Dose-time fractionation considerations. Radiother Oncol 1990;18:184-187.
41. Backlund EO, Ganz JC. Pituitary adenoma: Gamma knife. In Alexander E III, Loeffler JS, Lunsford LD, eds. Stereotactic Radiosurgery New York: McGraw-Hill, 1993:167-173.
42. Morange-Ramos I, Regis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P, Peragut JC. Short-term endocrinological results after gamma knife surgery of pituitary adenomas. Stereotact Funct Neurosurg 1998;70(Suppl 1):127-138.
43. Simmons NE, Laws ER Jr. Glioma occurrence after sellar irradiation: Case report and review. Neurosurgery 1998;42(1): 172-178.
44. Au WY, Chow WS, Lam KS, Ko GT, Cockram CS, Kwong YL. Acute leukemia in acromegaly patients. Br J Haematol 2000;110(4):871-873.
45. Sheppard MC. Aims of treatment and definition of cure. In: Wass JA, ed. Treating Acromegaly. Bristol: Bioscientifica Ltd., 1994:103-108.
46. Tishler RB, Loeffler JS. Lunsford LD, Duma C, Alexander E III, Kooy HM, Flickinger JC. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 1993;30;27(2):215-221.
47. Kim SH, Huh R, Chang JW, Park YG, Chung SS. Gamma knife radiosurgery for functioning pituitary adenomas. Stereotact Funct Neurosurg 1999;72(Suppl 1):101-110.
48. Lim YL, Leem W, Kim TS, Rhee BA, Kim GK. Four years' experiences in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotact Funct Neurosurg 1998;70(Suppl 1):95-109.
49. Morange-Ramos I, Regis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P, Peragut JC. Gamma-knife surgery for secreting pituitary adenomas. Acta Neurochir (Wien) 1998;140(5):437-443.
50. Kim MS, Lee SI, Sim JH. Gamma knife radiosurgery for functioning pituitary microadenoma. Stereotact Funct Neuros 1999;2(Suppl 1):119-124.
51. Park YG, Chang JW, Kim EY, Chung SS. Gamma knife surgery in pituitary microadenomas. Yonsei Med J 1996;37:165-173.
52. Pan L, Zang N, Wang Wxu. Pituitary adenoma: The effect of gamma knife radiosurgery on tumor growth and endocrinopathies. Stereotact Funct Neurosurg 1998;70(Suppl 1): 119-126.
53. Laws ER, Vance ML, Thapar K. Pituitary surgery for the management of acromegaly. Horm Res 2000;53(Suppl 3):71-75.
54. Martinez R, Bravo G, Burzaco J, Rey G. Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up. Stereotact Funct Neurosurg 1998;70(Suppl 1):110-118.
55. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G. Octreotide may act as a radioprotective agent in acromegaly. J Clinic Endocrinol Metab 2000;85(3): 1287-1289.
56. Degerblad M, Rahn T, Bergstrand G, Thoren M. Long term results of stereotactic radiosurgery to the pituitary gland in Cushing's disease. Acta Endocrinol (Copenh) 1986;112(3):310-314.
57. Steiner L, Lindquist C, Steiner M. Radiosurgery. Adv Tech Stand Neurosurg 1992;19:19-102.
58. Stephanian E, Lunsford LD, Coffey RJ, Bissonette J, Flickinger JC. Gamma knife surgery for sellar and suprasellar tumors. Neurosurg Clin N Am 1992;3(1):207-218.
59. Elster AD. modern imaging of pituitary. Radiol 1993;187:1-14.
60. Izawa M, Hayashi M, Nakaya K, Satoh H, Ochiai T, Hori T, Takakura K. Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 2000;93(Suppl 3):19-22.
61. Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF, Sandler HM. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 1997;82:3187-3191.
62. Inoue HK, Kohga H, Hirato M, Sasaki T, Ishihara J, Shibazaki T, Ohye C, Andou Y. Pituitary adenoma treated by microsurgery with or without gamma knife radiosurgery: Experience of 122 cases. Stereotac Funct Neurosur 1999;72(Suppl 1):125-131.
63. Shin M, Kurita H, Sasaki T, Tago M, Morita A, Ueki K, Kirino T. Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus. J Neurosurg 2000;93(Suppl 3):2-5.